|
|
231 Dundas Street East, P.O Box 1570
Belleville, Ontario K8N 5J2 Canada
phone:(613) 966-8058
fax:(613) 966-4177
|
|
| Symbol |
BNC |
| Exchange |
TSX |
| Founded |
0 |
| Employees |
|
|
|
| www.bioniche.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Product for the human and animal health markets. |
|
| Management |
| Graeme McRae, Chairman, President & Chief Executive Officer; Cindy Benning, Vice-President, Operations, Corporate Quality & Regulatory Affairs; Fran?ois Charette, Senior Vice-President and Chief Medical Officer; Rick Culbert, President, Bioniche Food Safety; Mohamed Elrafih, Vice-President, Manufacturing Operations; Andrew Grant, Divisional President, Bioniche Animal Health Export Sales, Europe and Australia; Cameron Groome, Executive Vice-President, Corporate & Strategic Development; Bruce McLeod, Vice-President, Human Resources; Patrick Montpetit, Vice President & Chief Financial Officer; Jim Phillips, President, Bioniche Animal Health (global); Dr. Nigel Phillips, Senior Vice President and Chief Scientific Officer; Dr. Dragan Rogan, Vice-President, Research & Development, Bioniche Animal Health; Jennifer Shea, Vice-President, Communications, Investor & Government Relations; Richard Sutin, Corporate Secretary (interim); Dr. Gary Weber, President, Bioniche Food Safety (U.S.) |
| |
|
|
|
|
|
|
|
| Keywords |
| oncology, inflammation, infectious diseases, InfectiousDisease |
|
|
|
| Description |
|
Bioniche Life Sciences is a biopharmaceutical company engaged in the research, development, production and commercialization of proprietary technologies for the human and animal health markets worldwide. |
|
| Products / Services |
The first product developed from this technology is Urocidin?, a formulation of Mycobacterial Cell Wall-DNA Complex (MCC) for the treatment of bladder cancer. A Phase III clinical program is underway, in partnership with Endo Pharmaceuticals Inc.
|
|
| Technology / Differentiation |
| Bioniche has developed a technology for the treatment of human cancers. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members